Arima T, Narumoto J, Shimomura H, Suwaki K, Kunishi K, Yasuhara T, Nagashima H
Gastroenterol Jpn. 1980;15(1):27-32. doi: 10.1007/BF02773701.
Serum Clq binding activity (ClqBA) is increased in diabetes mellitus with liver injury, carcinoma of gastrointestinal tract with metastatic liver and chronic liver disease (CLD). Significant elevations of ClqBA level are observed in the order of liver cirrhosis, chronic aggressive hepatitis and chronic persistent hepatitis. In CLD there are significant correlations between ClqBA and gamma-globulin, rheumatoid factor, anti-DNA-antibody, CH50, C3, C4, C3-activator and HBsAg.
血清Clq结合活性（ClqBA）在伴有肝损伤的糖尿病、伴有肝转移的胃肠道癌以及慢性肝病（CLD）中升高。在肝硬化、慢性侵袭性肝炎和慢性持续性肝炎中观察到ClqBA水平依次显著升高。在CLD中，ClqBA与γ-球蛋白、类风湿因子、抗DNA抗体、CH50、C3、C4、C3激活剂和HBsAg之间存在显著相关性。
Zotero 插件